e-learning
resources
Vienna 2012
Sunday, 02.09.2012
New mechanisms in non-neoplastic and neoplastic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Decreased Wnt/β-catenin signaling in COPD: Possible involvement of Wnt antagonists
L.L. Guo, T. Wang, L. Liu, C. Wan, F.Q. Wen (Chengdu, China)
Source:
Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases
Session:
New mechanisms in non-neoplastic and neoplastic lung diseases
Session type:
Oral Presentation
Number:
1402
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L.L. Guo, T. Wang, L. Liu, C. Wan, F.Q. Wen (Chengdu, China). Decreased Wnt/β-catenin signaling in COPD: Possible involvement of Wnt antagonists. Eur Respir J 2012; 40: Suppl. 56, 1402
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD
Source: Eur Respir J 2016; 47: 254-263
Year: 2016
Increased pulmonary Wnt signaling in patients with sarcoidosis
Source: Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties
Year: 2007
Hedgehog pathway activation is altered in COPD patients
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Notch pathway signaling in asthma
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006
Anti-tussive effects of FAAH inhibition: The role of endocannabinoids and downstream signalling pathways in the inhibition of vagal sensory nerve activation
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
The pathway to inflammation in asthma: the role of the DP2 receptor
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019
Wnt and TGF-beta signaling in lung development
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
Inhibition of VEGF blocks the activation of TGF-β
1
through a PI3K/Akt signaling pathway in allergic airway disease of mice
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007
Genetic variations in the TLR signaling pathway are associated with childhood asthma
Source: Annual Congress 2012 - Asthma and the genes: from GWAS to next generation transcriptome analyses
Year: 2012
LSC Abstract – Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
BMP-Smad1 target gene Wnt inhibitory factor 1 (WIF1) coordinates BMP and Wnt signaling activities in regulating lung development in vivo
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
BDNF-TrkB signaling mediates cholinergic neuroplasticity in asthma
Source: International Congress 2019 – Novel targets and mechanisms in asthma
Year: 2019
GCN2 regulates BMP signaling: consequence for PVOD pathobiology and therapeutic management
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension
Source: Eur Respir J 2016; 48: 470-483
Year: 2016
Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis
Source: ERS Lung Science Conference 2016
Year: 2016
Activation of WNT co-receptor LRP5 is required for WNT and TGF-ß1 induced fibroblast activation
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Genetic targeting of the pulmonary epithelium:
the role of TGF-b and wnt signaling in ontogeny of specialized cell types
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Effects of Liver X receptor agonist treatment on signal transduction pathways in acute lung inflammation
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept